High levels of ANXA2 are characteristic of malignant salivary gland tumors

Objective Malignant salivary gland tumors (MSGTs) present different phenotypic characteristics and various clinical outcomes, which proved to be a diagnostic challenge. Considering the heterogeneity of MSGT, this study aims to identify molecule related to the nature of MSGT. Methods For screening, p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of oral pathology & medicine 2019-11, Vol.48 (10), p.929-934
Hauptverfasser: Cardoso, Claudio Marcelo, de Jesus, Sabrina Ferreira, de Souza, Marcela Gonçalves, Queiroz, Lorena dos Reis Pereira, Santos, Eloa Mangabeira, Santos, Erivelton Pereira, Oliveira, Luis Paulo, Cordeiro Santos, Cristiane Karine, Santos, Sérgio Henrique Sousa, Paula, Alfredo Maurício Batista, Farias, Lucyana Conceição, Guimaraes, Andre Luiz Sena
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 934
container_issue 10
container_start_page 929
container_title Journal of oral pathology & medicine
container_volume 48
creator Cardoso, Claudio Marcelo
de Jesus, Sabrina Ferreira
de Souza, Marcela Gonçalves
Queiroz, Lorena dos Reis Pereira
Santos, Eloa Mangabeira
Santos, Erivelton Pereira
Oliveira, Luis Paulo
Cordeiro Santos, Cristiane Karine
Santos, Sérgio Henrique Sousa
Paula, Alfredo Maurício Batista
Farias, Lucyana Conceição
Guimaraes, Andre Luiz Sena
description Objective Malignant salivary gland tumors (MSGTs) present different phenotypic characteristics and various clinical outcomes, which proved to be a diagnostic challenge. Considering the heterogeneity of MSGT, this study aims to identify molecule related to the nature of MSGT. Methods For screening, proteomic analysis comparing MSGT with pleomorphic adenoma (PA) and salivary gland was performed. The MSGT‐associated protein which presented in the higher number in the Gene Expression Omnibus (GEO) database was selected. To validate the data, immunohistochemistry (IHC) was performed in 14 patients with PA, 22 patients with MSGT, and 14 controls. Results 16 proteins were associated with MSGT. ANXA2 was the primary protein, according to GEO database analyses. ANXA2 was most expressed in the cell membrane. However, some ANXA2 staining was also observed in the cytoplasm and nucleus. ANXA2 was highly expressed in MSGT in comparison with control. Also, ANXA2 has a higher expression in adenocarcinoma not otherwise specified (ANOS) and myoepithelial carcinoma (MC) in comparison with PA. Conclusion In conclusion, this study demonstrated that MSGT presented higher levels of ANXA2 in comparison with normal salivary glands. Also, ANXA2 might be interesting as a molecular marker of ANOS and MS.
doi_str_mv 10.1111/jop.12932
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2261969002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2261969002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3532-337b4351c0f4649fadc8dada039d962338f88dafb8ebd2bc23acce1de0c242323</originalsourceid><addsrcrecordid>eNp1kE1PwzAMhiMEYmNw4A-gSFzg0C2xu649ThMwJsQ4gMQtStN069QvknZo_56MDg5I-GLLfvzKfgm55GzIXYw2VT3kECEckT4PGPPYhPvHpM8i5nsw5tAjZ9ZuGOMT9Pkp6SFH1w6hTxbzbLWmud7q3NIqpdPn9ylQaTRVa2mkarTJbJOp_ayQebYqZdlQ66qtNDu6ymWZ0KYtKmPPyUkqc6svDnlA3u7vXmdz72n58DibPnkKxwge4iT2ccwVS_3Aj1KZqDCRiWQYJVEAiGEaukYahzpOIFaAUinNE80U-ICAA3LT6dam-mi1bUSRWaVzd4quWisAAh4FEWN79PoPuqlaU7rrBCAHh_kBOuq2o5SprDU6FbXJCvee4EzsDXZbtfg22LFXB8U2LnTyS_446oBRB3xmud79ryQWy5dO8gtm-4N8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2312196463</pqid></control><display><type>article</type><title>High levels of ANXA2 are characteristic of malignant salivary gland tumors</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Cardoso, Claudio Marcelo ; de Jesus, Sabrina Ferreira ; de Souza, Marcela Gonçalves ; Queiroz, Lorena dos Reis Pereira ; Santos, Eloa Mangabeira ; Santos, Erivelton Pereira ; Oliveira, Luis Paulo ; Cordeiro Santos, Cristiane Karine ; Santos, Sérgio Henrique Sousa ; Paula, Alfredo Maurício Batista ; Farias, Lucyana Conceição ; Guimaraes, Andre Luiz Sena</creator><creatorcontrib>Cardoso, Claudio Marcelo ; de Jesus, Sabrina Ferreira ; de Souza, Marcela Gonçalves ; Queiroz, Lorena dos Reis Pereira ; Santos, Eloa Mangabeira ; Santos, Erivelton Pereira ; Oliveira, Luis Paulo ; Cordeiro Santos, Cristiane Karine ; Santos, Sérgio Henrique Sousa ; Paula, Alfredo Maurício Batista ; Farias, Lucyana Conceição ; Guimaraes, Andre Luiz Sena</creatorcontrib><description>Objective Malignant salivary gland tumors (MSGTs) present different phenotypic characteristics and various clinical outcomes, which proved to be a diagnostic challenge. Considering the heterogeneity of MSGT, this study aims to identify molecule related to the nature of MSGT. Methods For screening, proteomic analysis comparing MSGT with pleomorphic adenoma (PA) and salivary gland was performed. The MSGT‐associated protein which presented in the higher number in the Gene Expression Omnibus (GEO) database was selected. To validate the data, immunohistochemistry (IHC) was performed in 14 patients with PA, 22 patients with MSGT, and 14 controls. Results 16 proteins were associated with MSGT. ANXA2 was the primary protein, according to GEO database analyses. ANXA2 was most expressed in the cell membrane. However, some ANXA2 staining was also observed in the cytoplasm and nucleus. ANXA2 was highly expressed in MSGT in comparison with control. Also, ANXA2 has a higher expression in adenocarcinoma not otherwise specified (ANOS) and myoepithelial carcinoma (MC) in comparison with PA. Conclusion In conclusion, this study demonstrated that MSGT presented higher levels of ANXA2 in comparison with normal salivary glands. Also, ANXA2 might be interesting as a molecular marker of ANOS and MS.</description><identifier>ISSN: 0904-2512</identifier><identifier>EISSN: 1600-0714</identifier><identifier>DOI: 10.1111/jop.12932</identifier><identifier>PMID: 31325182</identifier><language>eng</language><publisher>Denmark: Wiley Subscription Services, Inc</publisher><subject>Adenocarcinoma ; Adenoma ; Adenoma, Pleomorphic - metabolism ; Adenoma, Pleomorphic - pathology ; Annexin A2 - metabolism ; Biomarkers, Tumor - metabolism ; Carcinoma, Adenoid Cystic - metabolism ; Carcinoma, Adenoid Cystic - pathology ; Carcinoma, Mucoepidermoid - metabolism ; Carcinoma, Mucoepidermoid - pathology ; Case-Control Studies ; Cell membranes ; Cytoplasm ; Dentistry ; Gene expression ; gland ; Humans ; Immunohistochemistry ; malignancy ; metastasis ; neoplasm ; Oral cancer ; Proteome ; Proteomics ; Salivary gland ; Salivary Gland Neoplasms - metabolism ; Salivary Gland Neoplasms - pathology ; Tumors</subject><ispartof>Journal of oral pathology &amp; medicine, 2019-11, Vol.48 (10), p.929-934</ispartof><rights>2019 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><rights>2019 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2019 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3532-337b4351c0f4649fadc8dada039d962338f88dafb8ebd2bc23acce1de0c242323</citedby><cites>FETCH-LOGICAL-c3532-337b4351c0f4649fadc8dada039d962338f88dafb8ebd2bc23acce1de0c242323</cites><orcidid>0000-0002-3162-3206 ; 0000-0002-5379-361X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjop.12932$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjop.12932$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31325182$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cardoso, Claudio Marcelo</creatorcontrib><creatorcontrib>de Jesus, Sabrina Ferreira</creatorcontrib><creatorcontrib>de Souza, Marcela Gonçalves</creatorcontrib><creatorcontrib>Queiroz, Lorena dos Reis Pereira</creatorcontrib><creatorcontrib>Santos, Eloa Mangabeira</creatorcontrib><creatorcontrib>Santos, Erivelton Pereira</creatorcontrib><creatorcontrib>Oliveira, Luis Paulo</creatorcontrib><creatorcontrib>Cordeiro Santos, Cristiane Karine</creatorcontrib><creatorcontrib>Santos, Sérgio Henrique Sousa</creatorcontrib><creatorcontrib>Paula, Alfredo Maurício Batista</creatorcontrib><creatorcontrib>Farias, Lucyana Conceição</creatorcontrib><creatorcontrib>Guimaraes, Andre Luiz Sena</creatorcontrib><title>High levels of ANXA2 are characteristic of malignant salivary gland tumors</title><title>Journal of oral pathology &amp; medicine</title><addtitle>J Oral Pathol Med</addtitle><description>Objective Malignant salivary gland tumors (MSGTs) present different phenotypic characteristics and various clinical outcomes, which proved to be a diagnostic challenge. Considering the heterogeneity of MSGT, this study aims to identify molecule related to the nature of MSGT. Methods For screening, proteomic analysis comparing MSGT with pleomorphic adenoma (PA) and salivary gland was performed. The MSGT‐associated protein which presented in the higher number in the Gene Expression Omnibus (GEO) database was selected. To validate the data, immunohistochemistry (IHC) was performed in 14 patients with PA, 22 patients with MSGT, and 14 controls. Results 16 proteins were associated with MSGT. ANXA2 was the primary protein, according to GEO database analyses. ANXA2 was most expressed in the cell membrane. However, some ANXA2 staining was also observed in the cytoplasm and nucleus. ANXA2 was highly expressed in MSGT in comparison with control. Also, ANXA2 has a higher expression in adenocarcinoma not otherwise specified (ANOS) and myoepithelial carcinoma (MC) in comparison with PA. Conclusion In conclusion, this study demonstrated that MSGT presented higher levels of ANXA2 in comparison with normal salivary glands. Also, ANXA2 might be interesting as a molecular marker of ANOS and MS.</description><subject>Adenocarcinoma</subject><subject>Adenoma</subject><subject>Adenoma, Pleomorphic - metabolism</subject><subject>Adenoma, Pleomorphic - pathology</subject><subject>Annexin A2 - metabolism</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Carcinoma, Adenoid Cystic - metabolism</subject><subject>Carcinoma, Adenoid Cystic - pathology</subject><subject>Carcinoma, Mucoepidermoid - metabolism</subject><subject>Carcinoma, Mucoepidermoid - pathology</subject><subject>Case-Control Studies</subject><subject>Cell membranes</subject><subject>Cytoplasm</subject><subject>Dentistry</subject><subject>Gene expression</subject><subject>gland</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>malignancy</subject><subject>metastasis</subject><subject>neoplasm</subject><subject>Oral cancer</subject><subject>Proteome</subject><subject>Proteomics</subject><subject>Salivary gland</subject><subject>Salivary Gland Neoplasms - metabolism</subject><subject>Salivary Gland Neoplasms - pathology</subject><subject>Tumors</subject><issn>0904-2512</issn><issn>1600-0714</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1PwzAMhiMEYmNw4A-gSFzg0C2xu649ThMwJsQ4gMQtStN069QvknZo_56MDg5I-GLLfvzKfgm55GzIXYw2VT3kECEckT4PGPPYhPvHpM8i5nsw5tAjZ9ZuGOMT9Pkp6SFH1w6hTxbzbLWmud7q3NIqpdPn9ylQaTRVa2mkarTJbJOp_ayQebYqZdlQ66qtNDu6ymWZ0KYtKmPPyUkqc6svDnlA3u7vXmdz72n58DibPnkKxwge4iT2ccwVS_3Aj1KZqDCRiWQYJVEAiGEaukYahzpOIFaAUinNE80U-ICAA3LT6dam-mi1bUSRWaVzd4quWisAAh4FEWN79PoPuqlaU7rrBCAHh_kBOuq2o5SprDU6FbXJCvee4EzsDXZbtfg22LFXB8U2LnTyS_446oBRB3xmud79ryQWy5dO8gtm-4N8</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Cardoso, Claudio Marcelo</creator><creator>de Jesus, Sabrina Ferreira</creator><creator>de Souza, Marcela Gonçalves</creator><creator>Queiroz, Lorena dos Reis Pereira</creator><creator>Santos, Eloa Mangabeira</creator><creator>Santos, Erivelton Pereira</creator><creator>Oliveira, Luis Paulo</creator><creator>Cordeiro Santos, Cristiane Karine</creator><creator>Santos, Sérgio Henrique Sousa</creator><creator>Paula, Alfredo Maurício Batista</creator><creator>Farias, Lucyana Conceição</creator><creator>Guimaraes, Andre Luiz Sena</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3162-3206</orcidid><orcidid>https://orcid.org/0000-0002-5379-361X</orcidid></search><sort><creationdate>201911</creationdate><title>High levels of ANXA2 are characteristic of malignant salivary gland tumors</title><author>Cardoso, Claudio Marcelo ; de Jesus, Sabrina Ferreira ; de Souza, Marcela Gonçalves ; Queiroz, Lorena dos Reis Pereira ; Santos, Eloa Mangabeira ; Santos, Erivelton Pereira ; Oliveira, Luis Paulo ; Cordeiro Santos, Cristiane Karine ; Santos, Sérgio Henrique Sousa ; Paula, Alfredo Maurício Batista ; Farias, Lucyana Conceição ; Guimaraes, Andre Luiz Sena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3532-337b4351c0f4649fadc8dada039d962338f88dafb8ebd2bc23acce1de0c242323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adenocarcinoma</topic><topic>Adenoma</topic><topic>Adenoma, Pleomorphic - metabolism</topic><topic>Adenoma, Pleomorphic - pathology</topic><topic>Annexin A2 - metabolism</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Carcinoma, Adenoid Cystic - metabolism</topic><topic>Carcinoma, Adenoid Cystic - pathology</topic><topic>Carcinoma, Mucoepidermoid - metabolism</topic><topic>Carcinoma, Mucoepidermoid - pathology</topic><topic>Case-Control Studies</topic><topic>Cell membranes</topic><topic>Cytoplasm</topic><topic>Dentistry</topic><topic>Gene expression</topic><topic>gland</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>malignancy</topic><topic>metastasis</topic><topic>neoplasm</topic><topic>Oral cancer</topic><topic>Proteome</topic><topic>Proteomics</topic><topic>Salivary gland</topic><topic>Salivary Gland Neoplasms - metabolism</topic><topic>Salivary Gland Neoplasms - pathology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cardoso, Claudio Marcelo</creatorcontrib><creatorcontrib>de Jesus, Sabrina Ferreira</creatorcontrib><creatorcontrib>de Souza, Marcela Gonçalves</creatorcontrib><creatorcontrib>Queiroz, Lorena dos Reis Pereira</creatorcontrib><creatorcontrib>Santos, Eloa Mangabeira</creatorcontrib><creatorcontrib>Santos, Erivelton Pereira</creatorcontrib><creatorcontrib>Oliveira, Luis Paulo</creatorcontrib><creatorcontrib>Cordeiro Santos, Cristiane Karine</creatorcontrib><creatorcontrib>Santos, Sérgio Henrique Sousa</creatorcontrib><creatorcontrib>Paula, Alfredo Maurício Batista</creatorcontrib><creatorcontrib>Farias, Lucyana Conceição</creatorcontrib><creatorcontrib>Guimaraes, Andre Luiz Sena</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of oral pathology &amp; medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cardoso, Claudio Marcelo</au><au>de Jesus, Sabrina Ferreira</au><au>de Souza, Marcela Gonçalves</au><au>Queiroz, Lorena dos Reis Pereira</au><au>Santos, Eloa Mangabeira</au><au>Santos, Erivelton Pereira</au><au>Oliveira, Luis Paulo</au><au>Cordeiro Santos, Cristiane Karine</au><au>Santos, Sérgio Henrique Sousa</au><au>Paula, Alfredo Maurício Batista</au><au>Farias, Lucyana Conceição</au><au>Guimaraes, Andre Luiz Sena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High levels of ANXA2 are characteristic of malignant salivary gland tumors</atitle><jtitle>Journal of oral pathology &amp; medicine</jtitle><addtitle>J Oral Pathol Med</addtitle><date>2019-11</date><risdate>2019</risdate><volume>48</volume><issue>10</issue><spage>929</spage><epage>934</epage><pages>929-934</pages><issn>0904-2512</issn><eissn>1600-0714</eissn><abstract>Objective Malignant salivary gland tumors (MSGTs) present different phenotypic characteristics and various clinical outcomes, which proved to be a diagnostic challenge. Considering the heterogeneity of MSGT, this study aims to identify molecule related to the nature of MSGT. Methods For screening, proteomic analysis comparing MSGT with pleomorphic adenoma (PA) and salivary gland was performed. The MSGT‐associated protein which presented in the higher number in the Gene Expression Omnibus (GEO) database was selected. To validate the data, immunohistochemistry (IHC) was performed in 14 patients with PA, 22 patients with MSGT, and 14 controls. Results 16 proteins were associated with MSGT. ANXA2 was the primary protein, according to GEO database analyses. ANXA2 was most expressed in the cell membrane. However, some ANXA2 staining was also observed in the cytoplasm and nucleus. ANXA2 was highly expressed in MSGT in comparison with control. Also, ANXA2 has a higher expression in adenocarcinoma not otherwise specified (ANOS) and myoepithelial carcinoma (MC) in comparison with PA. Conclusion In conclusion, this study demonstrated that MSGT presented higher levels of ANXA2 in comparison with normal salivary glands. Also, ANXA2 might be interesting as a molecular marker of ANOS and MS.</abstract><cop>Denmark</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31325182</pmid><doi>10.1111/jop.12932</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-3162-3206</orcidid><orcidid>https://orcid.org/0000-0002-5379-361X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0904-2512
ispartof Journal of oral pathology & medicine, 2019-11, Vol.48 (10), p.929-934
issn 0904-2512
1600-0714
language eng
recordid cdi_proquest_miscellaneous_2261969002
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adenocarcinoma
Adenoma
Adenoma, Pleomorphic - metabolism
Adenoma, Pleomorphic - pathology
Annexin A2 - metabolism
Biomarkers, Tumor - metabolism
Carcinoma, Adenoid Cystic - metabolism
Carcinoma, Adenoid Cystic - pathology
Carcinoma, Mucoepidermoid - metabolism
Carcinoma, Mucoepidermoid - pathology
Case-Control Studies
Cell membranes
Cytoplasm
Dentistry
Gene expression
gland
Humans
Immunohistochemistry
malignancy
metastasis
neoplasm
Oral cancer
Proteome
Proteomics
Salivary gland
Salivary Gland Neoplasms - metabolism
Salivary Gland Neoplasms - pathology
Tumors
title High levels of ANXA2 are characteristic of malignant salivary gland tumors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T04%3A36%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20levels%20of%20ANXA2%20are%20characteristic%20of%20malignant%20salivary%20gland%20tumors&rft.jtitle=Journal%20of%20oral%20pathology%20&%20medicine&rft.au=Cardoso,%20Claudio%20Marcelo&rft.date=2019-11&rft.volume=48&rft.issue=10&rft.spage=929&rft.epage=934&rft.pages=929-934&rft.issn=0904-2512&rft.eissn=1600-0714&rft_id=info:doi/10.1111/jop.12932&rft_dat=%3Cproquest_cross%3E2261969002%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2312196463&rft_id=info:pmid/31325182&rfr_iscdi=true